טוען...
Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
PURPOSE: To evaluate the safety and efficacy of 0.003% tacrolimus suspension for the treatment of refractory vernal keratoconjunctivitis (VKC). MATERIALS AND METHODS: This prospective study included 40 eyes of 20 patients with severe VKC. After discontinuing all other medications, patients were trea...
שמור ב:
| הוצא לאור ב: | Oman J Ophthalmol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5657154/ https://ncbi.nlm.nih.gov/pubmed/29118487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ojo.OJO_232_2014 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|